{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T04:07:08Z","timestamp":1750738028257,"version":"3.41.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL132786"],"award-info":[{"award-number":["R01 HL132786"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>People with HIV have a higher risk of myocardial infarction (MI) compared with people without HIV. Real world evidence on whether the increased burden of MI in people with HIV is sustained over time is essential for understanding cardiovascular disease (CVD) patterns, optimizing management, and identifying unmet needs. To help fill this gap, we completed a cohort study of people with HIV and propensity matched people without HIV in two distinct US-based integrated healthcare systems (Kaiser Permanente Northern California and Mass General Brigham). Electronic health records were assessed for association of HIV status on MI risk in two calendar eras defined by baseline year: 2005\u20132009 and 2010\u20132017, with maximum 5-year follow-up, through 2020. Cox proportional hazards models were used to obtain adjusted hazard ratios (HR) for HIV status on MI risk overall and by cohort. Adjusted models controlled for demographics and traditional CVD risk factors. We included 9,401 people with HIV (78 with MI) and 29,418 people without HIV (204 with MI). In adjusted models, the HR for MI in people with HIV was 1.10 (95% CI, 0.76, 1.60) for years 2005\u20132009 and 1.66 (95% CI, 1.15, 2.39) for years 2010\u20132017 compared with people without HIV, with a corresponding P-interaction between HIV status and calendar era of 0.12. Differences were largely due to decreases in MI risk for people without HIV. The magnitude of HRs by calendar era was consistent across models stratified by cohort. Results showed an increased MI risk persisted among people with HIV in recent years relative to people without HIV, even as CVD rates are decreasing in the general population. In light of known HIV-specific CVD risk factors, continued surveillance for MIs is merited.<\/jats:p>","DOI":"10.1371\/journal.pone.0325773","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T17:36:31Z","timestamp":1750700191000},"page":"e0325773","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in Myocardial Infarction risk by HIV status in two U.S. healthcare systems"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6194-699X","authenticated-orcid":true,"given":"Alexandra N.","family":"Lea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asya","family":"Lyass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo B.","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel Q.","family":"Ehrbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor F.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila H.","family":"Borowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7194-9876","authenticated-orcid":true,"given":"Jorge","family":"Plutzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia A.","family":"Triant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"issue":"8","key":"pone.0325773.ref001","article-title":"Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association","volume":"145","author":"CW Tsao","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"pone.0325773.ref002","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/QAI.0000000000001996","article-title":"Factors Associated With Excess Myocardial Infarction Risk in HIV-Infected Adults: A Systematic Review and Meta-analysis","volume":"81","author":"SG Rao","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"pone.0325773.ref003","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association","volume":"140","author":"MJ Feinstein","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"pone.0325773.ref004","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26123","article-title":"Incidence of cardiometabolic outcomes among people living with HIV-1 initiated on integrase strand transfer inhibitor versus non-integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States","volume":"26","author":"PF Rebeiro","year":"2023","journal-title":"J Int AIDS Soc"},{"issue":"17","key":"pone.0325773.ref005","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"DAD Study Group","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"pone.0325773.ref006","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"201","author":"SW Worm","year":"2010","journal-title":"J Infect Dis"},{"issue":"6","key":"pone.0325773.ref007","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/ciz999","article-title":"Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials","volume":"71","author":"PE Sax","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"pone.0325773.ref008","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(22)00094-7","article-title":"Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium","volume":"9","author":"B Neesgaard","year":"2022","journal-title":"Lancet HIV"},{"issue":"2","key":"pone.0325773.ref009","article-title":"Changes in Body Mass Index Over Time in People With and Without HIV Infection","volume":"11","author":"JO Lam","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"pone.0325773.ref010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025874","article-title":"Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis","volume":"9","author":"O Eyawo","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"pone.0325773.ref011","first-page":"101","article-title":"The epidemiology, mechanisms, diagnosis and treatment of cardiovascular disease in adult patients with HIV","volume":"13","author":"RJ Henning","year":"2023","journal-title":"Am J Cardiovasc Dis"},{"issue":"5","key":"pone.0325773.ref012","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/QAI.0b013e3181f4b752","article-title":"Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system","volume":"55","author":"VA Triant","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"pone.0325773.ref013","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/QAI.0000000000000009","article-title":"Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care","volume":"65","author":"MJ Silverberg","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"pone.0325773.ref014","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41569-019-0219-9","article-title":"HIV infection and coronary heart disease: mechanisms and management","volume":"16","author":"PY Hsue","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"pone.0325773.ref015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/COH.0000000000000681","article-title":"Mechanisms and primary prevention of atherosclerotic cardiovascular disease among people living with HIV","volume":"16","author":"MS Durstenfeld","year":"2021","journal-title":"Curr Opin HIV AIDS"},{"key":"pone.0325773.ref016","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fcvm.2018.00185","article-title":"HIV proteins and endothelial dysfunction: implications in cardiovascular disease","volume":"5","author":"AR Anand","year":"2018","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"pone.0325773.ref017","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/v11030200","article-title":"Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART","volume":"11","author":"S Zicari","year":"2019","journal-title":"Viruses"},{"issue":"6","key":"pone.0325773.ref018","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11904-017-0368-6","article-title":"The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection","volume":"14","author":"JE Lake","year":"2017","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"pone.0325773.ref019","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41572-020-0181-1","article-title":"HIV and antiretroviral therapy-related fat alterations","volume":"6","author":"JR Koethe","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"pone.0325773.ref020","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-13-0967","article-title":"Metabolic and body composition effects of newer antiretrovirals in HIV-infected patients","volume":"170","author":"S Srinivasa","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"21","key":"pone.0325773.ref021","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1161\/CIRCULATIONAHA.117.028975","article-title":"Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection","volume":"137","author":"VA Triant","year":"2018","journal-title":"Circulation"},{"issue":"23","key":"pone.0325773.ref022","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa0908610","article-title":"Population trends in the incidence and outcomes of acute myocardial infarction","volume":"362","author":"RW Yeh","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0325773.ref023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210253","article-title":"Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: Impact of gender and immune status","volume":"14","author":"A Bald\u00e9","year":"2019","journal-title":"PLoS One"},{"key":"pone.0325773.ref024","article-title":"Decreasing rates of acute myocardial infarction in people living with HIV: a nationwide cohort study in Spain, 2004-2015","author":"M Masi\u00e1","year":"2018","journal-title":"HIV Med"},{"issue":"8","key":"pone.0325773.ref025","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/cid\/civ014","article-title":"Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care","volume":"60","author":"DB Klein","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"8","key":"pone.0325773.ref026","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/infdis\/jiab420","article-title":"Incidence of Cardiometabolic Diseases in People With and Without Human Immunodeficiency Virus in the United Kingdom: A Population-Based Matched Cohort Study","volume":"225","author":"TE Gooden","year":"2022","journal-title":"J Infect Dis"},{"issue":"9622","key":"pone.0325773.ref027","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(08)60423-7","article-title":"Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration","volume":"371","author":"Group D:A:D Study","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"pone.0325773.ref028","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/QAI.0b013e31819ff0e6","article-title":"Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline-sponsored clinical trials in adult subjects","volume":"51","author":"CH Brothers","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"pone.0325773.ref029","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/QAI.0b013e31826f993c","article-title":"No association of abacavir use with myocardial infarction: findings of an FDA meta-analysis","volume":"61","author":"X Ding","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"pone.0325773.ref030","article-title":"Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials","volume":"5","author":"C Nan","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"pone.0325773.ref031","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"Pitavastatin to Prevent Cardiovascular Disease in HIV Infection","volume":"389","author":"SK Grinspoon","year":"2023","journal-title":"N Engl J Med"},{"key":"pone.0325773.ref032","article-title":"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV","author":"U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2024"},{"issue":"1","key":"pone.0325773.ref033","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00098-22","article-title":"Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management","volume":"37","author":"I Nazari","year":"2024","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"pone.0325773.ref034","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11904-021-00567-w","article-title":"Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations","volume":"18","author":"AC Achhra","year":"2021","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"5","key":"pone.0325773.ref035","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/QAI.0000000000001450","article-title":"Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population","volume":"75","author":"DR Drozd","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"pone.0325773.ref036","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008661","article-title":"Impact of type 2 myocardial infarction (MI) on hospital-level MI outcomes: implications for quality and public reporting","volume":"7","author":"S Arora","year":"2018","journal-title":"J Am Heart Assoc"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T17:36:38Z","timestamp":1750700198000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325773"}},"subtitle":[],"editor":[{"given":"Kuo-Cherh","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0325773","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}